TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 1972-1976

  Hybertson, Brooks M ^a,b   Jepson, Eric K ^a   Cho, Okyong J ^a   Clarke, Jason H ^a   Lee, Young M ^a   Repine, John E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Webb Waring Antioxidant Res I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BINDING PROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; LUNG EDEMA; LUNG FLUID; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0031009086     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196104     Document Type: Article

References (37)

1. Siler, T. M., J. E. Swierkosz, T. M. Hyers, A. A. Fowler, and R. O. Webster. 1989. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp. Lung Res. 15:881-894.
2. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145:1016-1022.
3. Jacobs, R. F., D. R. Tabor, A. W. Burks, and G. D. Campbell. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:1686-1692.
4. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
5. Ulich, T. R., L. R. Watson, S. M. Yin, K. Z. Guo, P. Wang, H. Thang, and J. del Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1486-1496.
6. Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153:1850-1856.
7. Leff, J. A., J. W. Baer, M. E. Bodman, J. M. Kirkman, P. F. Shanley, L.M. Patton, C. J. Beehler, J. M. McCord, and J. E. Repine. 1994. Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats. Am. J. Physiol. 266:L2-L8.
8. Leff, J. A., M. E. Bodman, O. J. Cho, S. Rohrbach, O. K. Reiss, J. L. Vannice, and J. E. Repine. 1994. Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1. Am. J. Respir. Crit. Care Med. 150:109-112.
9. 1 posttreatment decreases IL-1 alpha-induced neutrophil accumulation and lung leak in rats. J. Appl. Physiol. 76:151-157.
10. Leff, J. A., C. P. Wilke, B. M. Hybertson, P. F. Shanley, C. J. Beehler, and J. E. Repine. 1993. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am. J. Physiol. 165:L501-L506.
11. Hybertson, B. M., J. A. Leff, C. J. Beehler, P. C. Barry, and J. E. Repine. 1995. Effect of vitamin E deficiency and supercritical fluid aerosolized vitamin E supplementation on interleukin-1-induced oxidative lung injury in rats. Free Radic. Biol. Med. 18:537-542.
12. Koh, Y., B. M. Hybertson, E. K. Jepson, O. J. Cho, and J. E. Repine. 1995. Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats. J. Appl. Physiol. 79:472-478.
13. Tang, G., J. E. White, P. D. Lumb, D. A. Lawrence, and M. F. Tsan. 1995. Role of endogenous cytokines in endotoxin- and interleukin-1-induced pulmonary inflammatory response and oxygen tolerance. Am. J. Respir. Cell Mol. Biol. 12:339-344.
14. Ikejima, R., S. Okusawa, P. Ghezzi, J. W. van der Meer, and C. A. Dinarello. 1990. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J. Infect. Dis. 162:215-223.
15. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, and S. F. Lowry. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
16. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, Jr., and J. V. O'Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163:1433-1450.
17. Larrick, J. W., and S. L. Kunkel. 1988. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharmacol. Res. 5:129-139.
18. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, III, A. Zentella, and J. D. Albert. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
19. Okusawa, S., J. A. Gelfand, T. Ikejima, R. J. Connolly, and C. A. Dinarello. 1988. Interleukin-1 induces a shock-like slate in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81:1162-1172.
20. Goldblum, S. E., K. Yoneda, D. A. Cohen, and C. J. McClain. 1988. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta. Infect. Immun. 56:2255-2263.
21. Wesselius, L. J., I. M. Smirnov, A. R. O'Brien-Ladner, and M. E. Nelson. 1995. Synergism of intratracheally administered tumor necrosis factor with interleukin-1 in the induction of lung edema in rats. J. Lab. Clin. Med. 125:618-625.
22. Koh, Y., B. M. Hybertson, E. K. Jepson, and J. E. Repine. 1996. Tumor necrosis factor induced acute lung leak in rats: less than with interleukin-1. Inflammation 20:461-469.
23. Nathan, C. F. 1987. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550-1560.
24. Kharazmi, A., H. Nielsen, and K. Bendtzen. 1988. Recombinant interleukin 1α and β prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils. Immunobiology 177:32-39.
25. Liles, W. C., J. A. Ledbetter, A. W. Waltersdorph, and S. J. Klebanoff. 1995. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J. Leukoc. Biol. 58:690-697.
26. Berkow, R. L., D. Wang, J. W. Larrick, R. W. Dodson, and T. H. Howard. 1987. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J. Immunol. 139:3783-3791.
27. Abraham, E., R. Wunderink, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, and R. Allred. 1995. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. J.A.M.A. 273:934-941.
28. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491-503.
29. Martin, D., S. L. Near, A. Bendele, and D. A. Russell. 1995. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 131:221-228.
30. Pizarro, T. T., K. Malinowska, E. J. Kovacs, J. Clancy, Jr., J. A. Robinson, and L. A. Piccinini. 1993. Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection. Transplantation 56:399-404.
31. Wittwer, A. J., L. S. Carr, J. Zagorski, G. J. Dolecki, B. A. Crippes, and J. E. De Larco. 1993. High-level expression of cytokine-induced neutrophil chemoattractant (CINC) by a metastatic rat cell line: purification and production of blocking antibodies. J. Cell Physiol. 156:421-427.
32. Krawisz, J. E., P. Sharon, and W. F. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350.
33. Allen, R. C. 1986. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 133:449-493.
34. Ulich, T. R., S. Yin, D. G. Remick, D. Russell, S. P. Eisenberg, and T. Kohno. 1993. Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142:1335-1338.
35. Ulich, T. R., E. S. Yi, S. Yin, C. Smith, and D. Remick, 1994. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72: 137-140.
36. Lukacs, N. W., R. M. Strieter, S. W. Chensue, M. Widmer, and S. L. Kunkel. 1995. TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154:5411-5417.
37. Abraham, E., W. F. Coulson, M. D. Schwartz, and J. Allbee. 1994. Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation. Clin. Exp. Immunol. 98:29-34.